Arcus Biosciences

Arcus Biosciences
Last activity: 09.03.2021
Categories: UniversityScienceResearchMedtechLivingGrowthDrugDevelopmentBioTechActive
Arcus is a biopharmaceutical company aiming to bring together scientists, physicians & advisors to focus on developing best-in-class cancer therapies.
Website visits
74.8K /mo.
Location: United States, California, Hayward
Employees: 201-500
Total raised: $177M
Founded date: 2015

Investors 8

Funding Rounds 2

13.11.2017Series C$107MGV
05.09.2016Series B$70MGV

Mentions in press and media 14

09.03.2021Arcus Biosciences Announces New Employment Inducement GrantsHAYWARD, Calif.--(BUSINESS WIRE)--Mar 9, 2021-- Arcus Biosciences, Inc. (NYSE:RCUS), an
24.02.2021Arcus Biosciences Reports Fourth Quarter and Full Year 2020 ...HAYWARD, Calif.--(BUSINESS WIRE)--Feb 24, 2021-- Arcus Biosciences, Inc. (NYSE:RCUS), an
28.05.2020Gilead enters $2B immuno-oncology deal with Arcus Bioscience...Under the deal, Gilead will pay Arcus $175 million upfront, as well as making a $200 million equity ...medcitynew...
27.05.2019NYSE changes fee schedule in bid to woo biotech companies“We are providing an improved on-ramp for biotech companies looking to access the public markets and...medcitynew...
20.02.2018Term Sheet — Tuesday, February 20IT’S ALL RITE Good morning, Term Sheet readers. Paid Content Securing the enterprise without
13.11.2017Arcus Biosciences closes $107M Series C round as industry hu...Additional therapies are needed to double-down on the tumor and to close any potential escape routes...medcitynew...
13.11.2017Arcus Biosciences Announces $107 Million Series C Financing ...HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, a clinical-stage biotechnology company focused on...aislingcap...
05.09.2016Arcus Biosciences Raises $70M from GVTaiho Ventures, LLC today announced its investment in Arcus Biosciences, Inc. of Hayward, California...citybizlis...
01.09.2016Arcus Biosciences Raises $70M in Series B FundingArcus Biosciences, a Hayward, California-based immuno-oncology company, raised an additional $70m
-Arcus Biosciences Announces New Employment Inducement GrantsHAYWARD, Calif.--(BUSINESS WIRE)--Feb 25, 2021-- Arcus Biosciences, Inc. (NYSE:RCUS), an
Show more

Reviews 0

Sign up to leave a review

Sign up Log In